Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Champlin

Showing results (571-580 of 671) with videos related to

Pageof 68
Sort By:
British Journal of Haematology|June 28, 2023
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplantOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Haematologica|April 23, 2010
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor typeLeandro de Padua Silva, Poliana A Patah, Rima M Saliba, et al.
American Journal of Hematology|June 19, 2023
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantationAlexandre Bazinet, Hagop Kantarjian, Naszrin Arani, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 19, 2016
Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipientsAla Abudayyeh, Amir Hamdi, Maen Abdelrahim, et al.
Hemasphere|February 16, 2026
Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapiesJayastu Senapati, Jennifer Croden, Guillermo Garcia-Manero, et al.
Blood Cancer Journal|May 17, 2024
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantationOren Pasvolsky, Zhongya Wang, Denái R Milton, et al.
Blood|May 16, 2012
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year resultsIssa F Khouri, Rima M Saliba, William D Erwin, et al.
Blood|July 15, 1997
Bone marrow transplantation for severe aplastic anemia: has outcome improved?J R Passweg, G Socié, W Hinterberger, et al.
Transplantation and Cellular Therapy|June 21, 2025
Inflammatory Markers and Microbiome Dysbiosis in Hematopoietic Cell Transplant Recipients with Lung Graft-versus-Host DiseaseVictoria Brehm, Ziyi Wang, Luis Rocha, et al.
JMIR Formative Research|February 7, 2022
Home-Based Spirometry Telemonitoring After Allogeneic Hematopoietic Cell Transplantation: Mixed Methods Evaluation of Acceptability and UsabilityAjay Sheshadri, Sukh Makhnoon, Amin M Alousi, et al.
Pageof 68

Showing results (571-580 of 671) with videos related to

Sort By:
Pageof 68
British Journal of Haematology|June 28, 2023
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplantOren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Haematologica|April 23, 2010
Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor typeLeandro de Padua Silva, Poliana A Patah, Rima M Saliba, et al.
American Journal of Hematology|June 19, 2023
Evolving trends and outcomes in older patients with acute myeloid leukemia including allogeneic stem cell transplantationAlexandre Bazinet, Hagop Kantarjian, Naszrin Arani, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|November 19, 2016
Poor immune reconstitution is associated with symptomatic BK polyomavirus viruria in allogeneic stem cell transplant recipientsAla Abudayyeh, Amir Hamdi, Maen Abdelrahim, et al.
Hemasphere|February 16, 2026
Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapiesJayastu Senapati, Jennifer Croden, Guillermo Garcia-Manero, et al.
Blood Cancer Journal|May 17, 2024
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantationOren Pasvolsky, Zhongya Wang, Denái R Milton, et al.
Blood|May 16, 2012
Nonmyeloablative allogeneic transplantation with or without 90yttrium ibritumomab tiuxetan is potentially curative for relapsed follicular lymphoma: 12-year resultsIssa F Khouri, Rima M Saliba, William D Erwin, et al.
Blood|July 15, 1997
Bone marrow transplantation for severe aplastic anemia: has outcome improved?J R Passweg, G Socié, W Hinterberger, et al.
Transplantation and Cellular Therapy|June 21, 2025
Inflammatory Markers and Microbiome Dysbiosis in Hematopoietic Cell Transplant Recipients with Lung Graft-versus-Host DiseaseVictoria Brehm, Ziyi Wang, Luis Rocha, et al.
JMIR Formative Research|February 7, 2022
Home-Based Spirometry Telemonitoring After Allogeneic Hematopoietic Cell Transplantation: Mixed Methods Evaluation of Acceptability and UsabilityAjay Sheshadri, Sukh Makhnoon, Amin M Alousi, et al.
Pageof 68